Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report

Benjamin Peter Michael Gummlich; Ali Seif Amir Hosseini; Harald Schwörer

doi:10.12659/AJCR.938272

08 December 2022 : Case report Germany

Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report

Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)

Benjamin Peter Michael Gummlich^1ABCDEF, Ali Seif Amir Hosseini^2BC, Harald Schwörer^1ABCDF*

DOI: 10.12659/AJCR.938272

Am J Case Rep 2022; 23:e938272

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy